P2RY12 and acute coronary syndrome: Dual antiplatelet therapy (DAPT), combining aspirin and a P2Y12 inhibitor, is the cornerstone in the prevention of ischemic events after an acute coronary syndrome (ACS) and/or a percutaneous coronary intervention (PCI).